Edition 7 – Public Health and the Policing of Black Lives

Edition 7 – Public Health and the Policing of Black Lives

Public Health and the Policing of Black Lives By Justin Feldman, MPH, MSW Citation Feldman J. Public health and the policing of Black lives. Harvard Public Health Review. Summer 2015;7. Public Health and the Policing of Black Lives The deaths of Michael Brown, Eric Garner, Freddie Gray, Rekia Boyd, and Walter Scott reflect a pattern of […]

Mandating the COVID-19 Vaccine Part II by HPHR Fellow Priya Vedula

It seems that the key question is not whether we can or cannot mandate; rather, it is whether we should. It seems peculiar that many prominent people who are vaccinated or who understand the importance of the vaccine are choosing to either stay silent about it or actively oppose it.

Edition 28 – Legal Obstacles to Biosimilar Market Entry

Legal Obstacles to Biosimilar Market Entry By Laura Karas, MD, MPH; Rachel Sachs, JD, MPH; Gerard Anderson, PhD Citation Karas L, Sachs R, Anderson G. Legal obstacles to biosimilar market entry. HPHR. 2021;28.  DOI:10.54111/0001/bb2 Legal Obstacles to Biosimilar Market Entry Abstract Improving the market availability and penetration of biosimilars, “follow-on” versions of biologic products, will […]

Edition 28 – Financial Toxicity as an Unforeseen Side Effect of Inflammatory Bowel Disease

Financial Toxicity as an Unforeseen Side Effect of Inflammatory Bowel Disease By Misty Hobbs Citation Hobbs M. Financial toxicity as an unforeseen side effect of inflammatory bowel disease. HPHR. 2021;28. DOI:10.54111/0001/bb3 Financial Toxicity as an Unforeseen Side Effect of Inflammatory Bowel Disease A 32-year-old male with a history of ulcerative colitis diagnosed at age 26 […]